Twist Bioscience
Update in progressTWST (NasdaqGS)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryBiotechnology
Twist Bioscience manufactures and sells synthetic DNA products for therapeutics, diagnostics, chemicals, food/agriculture, data storage, and academic research. Its offerings include synthetic genes, gene fragments, and oligo pools for targeted sequencing, CRISPR experiments, DNA origami, and data storage; NGS tools, methylation and RNA sequencing workflows; viral controls and diagnostic panels; and antibody engineering solutions. HQ in South San Francisco; founded 2013; collaborates with BitBiome.
Company score
- Sentiment
- -0.29
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.15
- Governance
- -0.56
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- -0.07
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- -0.18
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNasdaqGS (NMS)
- LocationUnited States
- CEODr. Emily Marine Leproust Ph.D.
- Founded2013
- Employees979
- Websitewww.twistbioscience.com
Identifiers
- ISINUS90184D1000
- FIGIBBG006KDCHJ4
- LEI549300T23BL59LCOH584
- CUSIP90184D100
- CIK0001581280